
cultivate(MD) is a medical device venture capital firm based in Grand Rapids, Michigan, investing in early-stage healthcare and medical device companies with technologies that improve patient outcomes and reduce healthcare costs.
Their most common stage is series-a (50% of deals). Average disclosed round size is $7.2M (across 12 rounds with reported amounts).
Portfolio
13
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $4.1M | Jan 2026 | |
| PPrana Thoracic | Series A | $3M | Aug 2024 |
| YYoona International Pte. Ltd. | Seed | — | Nov 2023 |
| Series C | $30M | Sep 2023 | |
| Series A | $3M | Jan 2023 | |
| SSpinTech | Series A | $6.5M | Jan 2023 |
| EEmbody, Inc. | Series C | $10.4M | Sep 2022 |
| Seed | $4.5M | Jan 2022 | |
| SStrados | Series A | $4.5M | Jan 2022 |
| Seed | — | Dec 2020 | |
| MMagnesium Development | Unknown | $1M | — |
| SSpinTech MRI | Series A | $6.5M | — |
| PPrana Surgical | Series A | $3M | — |
| EEmbody, Inc. | Series A | $9.3M | — |
Top Co-Investors
SOSV2 shared
Blu Ventures1 shared
Wavemaker Three-Sixty Health1 shared
GapMinder1 shared
Context Ventures1 shared
CyberAgent Capital1 shared
Baird1 shared
Bluestem Capital Company1 shared
Endeavour Vision1 shared
Johnson & Johnson Innovation1 shared
Last updated: 8 September 2026